IL-17B/RB Activation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Metabolism and Growth
Overview
Authors
Affiliations
In pancreatic ductal adenocarcinoma (PDAC), the tumor stroma constitutes most of the cell mass and contributes to therapy resistance and progression. Here we show a hitherto unknown metabolic cooperation between pancreatic stellate cells (PSCs) and tumor cells through Interleukin 17B/Interleukin 17B receptor (IL-17B/IL-17RB) signaling. Tumor-derived IL-17B carrying extracellular vesicles (EVs) activated stromal PSCs and induced the expression of IL-17RB. PSCs increased oxidative phosphorylation while reducing mitochondrial turnover. PSCs activated tumor cells in a feedback loop. Tumor cells subsequently increased oxidative phosphorylation and decreased glycolysis partially via IL-6. In vivo, IL-17RB overexpression in PSCs accelerated tumor growth in a co-injection xenograft mouse model. Our results demonstrate a tumor-to-stroma feedback loop increasing tumor metabolism to accelerate tumor growth under optimal nutritional conditions.
The role of interleukin-17 in inflammation-related cancers.
Zhang X, Li B, Lan T, Chiari C, Ye X, Wang K Front Immunol. 2025; 15:1479505.
PMID: 39906741 PMC: 11790576. DOI: 10.3389/fimmu.2024.1479505.
Peng W, Zhao Y, Yang N, Fang Y, Wu Y, Feng Z Discov Oncol. 2025; 16(1):113.
PMID: 39899137 PMC: 11790549. DOI: 10.1007/s12672-025-01843-6.
Role and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review).
Liu W, Wang X, Wu W Oncol Rep. 2024; 52(5).
PMID: 39219271 PMC: 11378154. DOI: 10.3892/or.2024.8803.
Mechanistic Insights into the Roles of the IL-17/IL-17R Families in Pancreatic Cancer.
Chen Z, Qiao S, Yang L, Sun M, Li B, Lu A Int J Mol Sci. 2023; 24(17).
PMID: 37686343 PMC: 10487659. DOI: 10.3390/ijms241713539.
Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy.
Wang Z, He R, Dong S, Zhou W Front Oncol. 2023; 13:1185093.
PMID: 37409257 PMC: 10318188. DOI: 10.3389/fonc.2023.1185093.